Want to see IN:LASA full AI Analyst Report?
Lasa Supergenerics Ltd. (LASA) Revenue
Lasa Supergenerics Ltd. Revenue
Lasa Supergenerics Ltd. had a revenue of 12.27M in the quarter ending Jun 30, 2026, with 1032.85%. This bring the company's revenue in the last twelve months to 63.56M, Decreased 74.72%. In the fiscal year ending Mar 31, 2026, Lasa Supergenerics Ltd. had annual revenue of 251.41M with -82.35% growth.
- Revenue (ttm)
- 63.56M
- Revenue Growth
- -95.17%
- P/S Ratio
- 1.00
- Revenue/Employee
- INR 27,934,111
- Employees
- 9
- Market Cap
- INR 252.01M
Revenue Chart
Lasa Supergenerics Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 251.41M | -1.17B | -82.35% |
| Mar 31, 2025 | 1.42B | 381.13M | 36.53% |
| Mar 31, 2024 | 1.04B | -252.33M | -19.47% |
| Mar 31, 2023 | 1.30B | -75.59M | -5.51% |
| Mar 31, 2022 | 1.37B | -652.53M | -32.24% |
| Mar 31, 2021 | 2.02B | 351.23M | 21.00% |
| Mar 31, 2020 | 1.67B | -23.16M | -1.37% |
| Mar 31, 2019 | 1.70B | -739.53M | -30.37% |
| Mar 31, 2018 | 2.44B | 447.75M | 22.53% |
| Mar 31, 2017 | 1.99B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:LASA | 63.56M |
| IN:BALPHARMA | 3.34B |
| IN:BIOFILCHEM | 343.13M |
| IN:MANGALAM | 2.32B |
| IN:PAR | 1.09B |
| IN:VIVIMEDLAB | 699.89M |